| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | DRP2 TRIM42 TRIM58 ZNF875 TRIM41 DYTN TRIM39 ADAMTS8 ADAMTS5 RPS29 SIRT6 RNF217 CXXC1 NR1I2 ADAMTS9 SYTL4 TRIM32 ADAMTS15 PRKN NR5A1 PLSCR2 NBR1 PDZRN3 | 1.38e-06 | 891 | 166 | 23 | GO:0008270 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF438 ZNF133 SP3 TCF15 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 CPHXL2 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 RFX5 ZNF707 ZNF17 NR1I2 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 DMRTB1 DMRTA2 NR5A1 PLSCR2 ZNF646 | 1.73e-06 | 1412 | 166 | 30 | GO:0000981 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RNF168 TRIM58 TRIM41 RFFL TRIM39 RNF217 FBXO24 UBE2J2 FBXO9 TRIM32 ZNF451 RLIM PRKN NEURL1B MED23 PDZRN3 | 6.07e-06 | 512 | 166 | 16 | GO:0019787 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | DHX36 SP3 TCF15 SALL3 ZNF274 OVOL3 ZNF689 CPHXL2 ZNF202 ZKSCAN2 ZNF236 ZNF467 RFX5 CXXC1 ZNF707 ZNF17 NR1I2 SALL2 KLF1 MZF1 ZNF408 SP6 NLRC5 DMRTB1 DMRTA2 NR5A1 ZNF646 | 6.21e-06 | 1271 | 166 | 27 | GO:0000987 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RNF168 TRIM58 TRIM41 RFFL TRIM39 RNF217 FBXO24 UBE2J2 FBXO9 TRIM32 ZNF451 RLIM PRKN NEURL1B MED23 PDZRN3 | 9.79e-06 | 532 | 166 | 16 | GO:0016755 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | RNF168 TRIM58 TRIM41 RFFL TRIM39 RNF217 FBXO24 UBE2J2 FBXO9 TRIM32 RLIM PRKN NEURL1B MED23 PDZRN3 | 1.01e-05 | 473 | 166 | 15 | GO:0004842 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | DHX36 SP3 TCF15 SALL3 ZNF274 OVOL3 ZNF689 CPHXL2 ZNF202 ZKSCAN2 ZNF236 ZNF467 RFX5 ZNF707 ZNF17 NR1I2 SALL2 KLF1 MZF1 ZNF408 SP6 NLRC5 DMRTB1 DMRTA2 NR5A1 ZNF646 | 1.26e-05 | 1244 | 166 | 26 | GO:0000978 |
| GeneOntologyMolecularFunction | acyltransferase activity | RNF168 TRIM58 TRIM41 RFFL TRIM39 SIRT6 RNF217 FBXO24 UBE2J2 FBXO9 BAZ1A TRIM32 ZNF451 RLIM PRKN CERS1 NEURL1B MED23 PDZRN3 | 2.51e-05 | 775 | 166 | 19 | GO:0016746 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | DHX36 ZNF133 SP3 TCF15 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 CPHXL2 ZNF202 ZKSCAN2 ZNF236 ZNF467 RFX5 ZNF707 ZNF17 NR1I2 SALL2 KLF1 MZF1 ZNF408 SP6 NLRC5 DMRTB1 DMRTA2 NR5A1 ZNF646 | 2.67e-05 | 1459 | 166 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RNF168 TRIM58 TRIM41 RFFL TRIM39 RNF217 TRIM32 ZNF451 RLIM PRKN NEURL1B MED23 PDZRN3 | 2.96e-05 | 398 | 166 | 13 | GO:0061659 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.54e-05 | 120 | 166 | 7 | GO:0004222 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | RNF168 TRIM58 TRIM41 RFFL TRIM39 RNF217 TRIM32 RLIM PRKN NEURL1B MED23 PDZRN3 | 6.81e-05 | 372 | 166 | 12 | GO:0061630 |
| GeneOntologyMolecularFunction | transition metal ion binding | DRP2 TRIM42 TRIM58 ZNF875 TRIM41 DYTN TRIM39 ADAMTS8 ADAMTS5 RPS29 SIRT6 RNF217 CXXC1 NR1I2 ADAMTS9 SYTL4 TRIM32 ADAMTS15 PRKN NR5A1 PLSCR2 NBR1 PDZRN3 | 1.35e-04 | 1189 | 166 | 23 | GO:0046914 |
| GeneOntologyMolecularFunction | ubiquitin binding | 2.73e-04 | 107 | 166 | 6 | GO:0043130 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 2.92e-04 | 16 | 166 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.56e-04 | 73 | 166 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 PCDHGC4 PCDHB10 PCDHB7 PCDHB2 VWCE LRP1B FBLN1 MEGF6 SLIT1 LTBP2 PLSCR2 VWA2 LTBP4 AGRN NOTCH3 | 5.27e-04 | 749 | 166 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 7.09e-04 | 128 | 166 | 6 | GO:0032182 | |
| GeneOntologyMolecularFunction | endopeptidase activity | USP34 HGF PRTN3 RHBDF2 ADAMTS8 ADAMTS5 ADAM32 ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 9.68e-04 | 430 | 166 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.01e-03 | 188 | 166 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.27e-03 | 26 | 166 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RAF1 PRKD2 TRIO PPM1D MAST2 PRKD3 EGFR MARK4 IRAK3 PRKD1 LTBP4 | 1.30e-03 | 446 | 166 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.45e-03 | 200 | 166 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.85e-03 | 268 | 166 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.86e-03 | 8 | 166 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.96e-03 | 156 | 166 | 6 | GO:0019838 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THSD4 FRAS1 PRTN3 CFP ADAMTS8 ADAMTS5 SSPOP SSC5D FBLN1 MEGF6 ADAMTS9 ADAMTS17 ADAMTS15 LTBP2 PLSCR2 VWA2 LTBP4 AGRN | 2.20e-07 | 530 | 165 | 18 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 FRAS1 PRTN3 CFP ADAMTS8 ADAMTS5 SSPOP SSC5D FBLN1 MEGF6 ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 LTBP2 PLSCR2 VWA2 LTBP4 AGRN | 1.11e-06 | 656 | 165 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 FRAS1 PRTN3 CFP ADAMTS8 ADAMTS5 SSPOP SSC5D FBLN1 MEGF6 ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 LTBP2 PLSCR2 VWA2 LTBP4 AGRN | 1.16e-06 | 658 | 165 | 19 | GO:0030312 |
| Domain | TSP_1 | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 1.88e-10 | 63 | 165 | 10 | PF00090 |
| Domain | TSP1 | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 2.59e-10 | 65 | 165 | 10 | SM00209 |
| Domain | TSP1_rpt | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 2.59e-10 | 65 | 165 | 10 | IPR000884 |
| Domain | TSP1 | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 2.59e-10 | 65 | 165 | 10 | PS50092 |
| Domain | EGF | CNTNAP3B FRAS1 STAB2 TMEM8B CNTNAP3 ADAM32 VWCE LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 3.06e-10 | 235 | 165 | 16 | SM00181 |
| Domain | EGF_3 | CNTNAP3B STAB2 TMEM8B CNTNAP3 ADAM32 VWCE SSPOP LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 3.06e-10 | 235 | 165 | 16 | PS50026 |
| Domain | ADAM_spacer1 | 8.05e-10 | 23 | 165 | 7 | IPR010294 | |
| Domain | ADAM_spacer1 | 8.05e-10 | 23 | 165 | 7 | PF05986 | |
| Domain | EGF_1 | CNTNAP3B STAB2 TMEM8B CNTNAP3 ADAM32 VWCE SSPOP LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 1.01e-09 | 255 | 165 | 16 | PS00022 |
| Domain | EGF_2 | CNTNAP3B STAB2 TMEM8B CNTNAP3 ADAM32 VWCE SSPOP LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 1.77e-09 | 265 | 165 | 16 | PS01186 |
| Domain | EGF-like_dom | CNTNAP3B FRAS1 STAB2 CNTNAP3 ADAM32 VWCE LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 6.02e-09 | 249 | 165 | 15 | IPR000742 |
| Domain | EGF_CA | STAB2 VWCE LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 1.10e-08 | 122 | 165 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | STAB2 VWCE LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 1.31e-08 | 124 | 165 | 11 | IPR001881 |
| Domain | Znf_C2H2 | ZNF438 ZNF133 SP3 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 ADAMTS17 SP6 ZNF687 ZNF646 | 4.25e-08 | 805 | 165 | 25 | IPR007087 |
| Domain | Pep_M12B_propep | 4.48e-08 | 39 | 165 | 7 | PF01562 | |
| Domain | Peptidase_M12B_N | 4.48e-08 | 39 | 165 | 7 | IPR002870 | |
| Domain | zf-C2H2 | ZNF438 ZNF133 SP3 SALL3 ZNF274 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 ZNF687 ZNF646 | 4.75e-08 | 693 | 165 | 23 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF438 ZNF133 SP3 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF408 SP6 ZNF687 ZNF646 | 4.87e-08 | 694 | 165 | 23 | IPR013087 |
| Domain | Peptidase_M12B_ADAM-TS | 5.12e-08 | 24 | 165 | 6 | IPR013273 | |
| Domain | DISINTEGRIN_1 | 5.39e-08 | 40 | 165 | 7 | PS00427 | |
| Domain | Reprolysin | 5.39e-08 | 40 | 165 | 7 | PF01421 | |
| Domain | ADAM_MEPRO | 5.39e-08 | 40 | 165 | 7 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.39e-08 | 40 | 165 | 7 | PS50214 | |
| Domain | Peptidase_M12B | 5.39e-08 | 40 | 165 | 7 | IPR001590 | |
| Domain | Disintegrin_dom | 6.46e-08 | 41 | 165 | 7 | IPR001762 | |
| Domain | EGF-like_CS | STAB2 TMEM8B CNTNAP3 ADAM32 VWCE LRP1B FBLN1 MEGF6 SLIT1 LTBP2 VWA2 LTBP4 AGRN NOTCH3 | 8.44e-08 | 261 | 165 | 14 | IPR013032 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ZNF133 SP3 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 ZNF687 ZNF646 | 8.62e-08 | 775 | 165 | 24 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ZNF133 SP3 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 ZNF687 ZNF646 | 9.04e-08 | 777 | 165 | 24 | PS00028 |
| Domain | Znf_RING/FYVE/PHD | RNF168 TRIM42 TRIM58 TRIM41 PHF6 RNF222 RFFL TRIM39 CXXC1 ZFYVE28 SYTL4 BAZ1A TRIM32 RLIM RIMS1 NEURL1B RIMS2 PDZRN3 | 1.36e-07 | 459 | 165 | 18 | IPR013083 |
| Domain | Growth_fac_rcpt_ | FRAS1 STAB2 VWCE LRP1B FBLN1 MEGF6 EGFR SLIT1 LTBP2 LTBP4 NOTCH3 | 1.41e-07 | 156 | 165 | 11 | IPR009030 |
| Domain | Znf_C2H2-like | ZNF438 ZNF133 SP3 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 ZNF687 ZNF646 | 1.41e-07 | 796 | 165 | 24 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF438 ZNF133 SP3 SALL3 ZNF274 OVOL3 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 ZNF687 ZNF646 | 1.86e-07 | 808 | 165 | 24 | SM00355 |
| Domain | - | RNF168 TRIM58 TRIM41 PHF6 RNF222 RFFL TRIM39 CXXC1 ZFYVE28 SYTL4 BAZ1A TRIM32 RLIM RIMS1 NEURL1B RIMS2 PDZRN3 | 5.05e-07 | 449 | 165 | 17 | 3.30.40.10 |
| Domain | - | ZNF438 ZNF133 SP3 SALL3 ZNF274 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF408 SP6 ZNF646 | 6.11e-07 | 679 | 165 | 21 | 3.30.160.60 |
| Domain | Protein_Kinase_C_mu-related | 6.77e-07 | 3 | 165 | 3 | IPR015727 | |
| Domain | EGF | 1.79e-06 | 126 | 165 | 9 | PF00008 | |
| Domain | ZF_RING_1 | RNF168 TRIM42 TRIM58 TRIM41 RNF222 RFFL TRIM39 RNF217 TRIM32 RLIM PRKN NEURL1B PDZRN3 | 1.96e-06 | 291 | 165 | 13 | PS00518 |
| Domain | EGF_Ca-bd_CS | 2.32e-06 | 97 | 165 | 8 | IPR018097 | |
| Domain | ZF_RING_2 | RNF168 TRIM42 TRIM58 TRIM41 RNF222 RFFL TRIM39 RNF217 TRIM32 RLIM PRKN NEURL1B PDZRN3 | 2.55e-06 | 298 | 165 | 13 | PS50089 |
| Domain | EGF_CA | 2.71e-06 | 99 | 165 | 8 | PS01187 | |
| Domain | RING | RNF168 TRIM42 TRIM58 TRIM41 RNF222 RFFL TRIM39 SYTL4 BAZ1A TRIM32 RLIM NEURL1B PDZRN3 | 3.29e-06 | 305 | 165 | 13 | SM00184 |
| Domain | ADAM_Cys-rich | 3.49e-06 | 27 | 165 | 5 | IPR006586 | |
| Domain | ACR | 3.49e-06 | 27 | 165 | 5 | SM00608 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.53e-06 | 106 | 165 | 8 | IPR000152 | |
| Domain | Znf_RING | RNF168 TRIM42 TRIM58 TRIM41 RNF222 RFFL TRIM39 SYTL4 BAZ1A TRIM32 RLIM NEURL1B PDZRN3 | 6.77e-06 | 326 | 165 | 13 | IPR001841 |
| Domain | - | 7.43e-06 | 81 | 165 | 7 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 7.43e-06 | 81 | 165 | 7 | IPR024079 | |
| Domain | EGF_CA | 1.11e-05 | 86 | 165 | 7 | PF07645 | |
| Domain | EGF_extracell | 1.46e-05 | 60 | 165 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.46e-05 | 60 | 165 | 6 | PF07974 | |
| Domain | Znf_FYVE | 2.01e-05 | 38 | 165 | 5 | IPR000306 | |
| Domain | ZF_FYVE | 2.60e-05 | 40 | 165 | 5 | PS50178 | |
| Domain | ASX_HYDROXYL | 2.97e-05 | 100 | 165 | 7 | PS00010 | |
| Domain | DAG/PE-bd | 3.13e-05 | 21 | 165 | 4 | IPR020454 | |
| Domain | Pept_M12B_ADAM-TS8 | 7.76e-05 | 2 | 165 | 2 | IPR013277 | |
| Domain | FYVE_2 | 1.06e-04 | 11 | 165 | 3 | PF02318 | |
| Domain | RABBD | 1.40e-04 | 12 | 165 | 3 | PS50916 | |
| Domain | Rab_BD | 1.40e-04 | 12 | 165 | 3 | IPR010911 | |
| Domain | Znf_C3HC4_RING-type | 1.48e-04 | 172 | 165 | 8 | IPR018957 | |
| Domain | zf-C3HC4 | RNF168 TRIM42 TRIM58 TRIM41 RNF222 TRIM39 TRIM32 RLIM PDZRN3 | 1.68e-04 | 223 | 165 | 9 | PF00097 |
| Domain | ZINC_PROTEASE | 2.34e-04 | 98 | 165 | 6 | PS00142 | |
| Domain | Znf_FYVE_PHD | 3.34e-04 | 147 | 165 | 7 | IPR011011 | |
| Domain | LAM_G_DOMAIN | 3.43e-04 | 38 | 165 | 4 | PS50025 | |
| Domain | BBOX | 3.61e-04 | 69 | 165 | 5 | SM00336 | |
| Domain | CYSTEINE_SWITCH | 4.61e-04 | 41 | 165 | 4 | PS00546 | |
| Domain | ZF_ZZ_2 | 5.01e-04 | 18 | 165 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 5.01e-04 | 18 | 165 | 3 | PS01357 | |
| Domain | ZZ | 5.01e-04 | 18 | 165 | 3 | PF00569 | |
| Domain | Pept_M10_metallopeptidase | 5.54e-04 | 43 | 165 | 4 | IPR001818 | |
| Domain | VWC_out | 5.91e-04 | 19 | 165 | 3 | SM00215 | |
| Domain | PLAC | 5.91e-04 | 19 | 165 | 3 | PS50900 | |
| Domain | Znf_ZZ | 5.91e-04 | 19 | 165 | 3 | IPR000433 | |
| Domain | PLAC | 5.91e-04 | 19 | 165 | 3 | IPR010909 | |
| Domain | ZnF_ZZ | 5.91e-04 | 19 | 165 | 3 | SM00291 | |
| Domain | LamG | 6.05e-04 | 44 | 165 | 4 | SM00282 | |
| Domain | Znf_RING_CS | 6.22e-04 | 163 | 165 | 7 | IPR017907 | |
| Domain | ZF_BBOX | 7.14e-04 | 80 | 165 | 5 | PS50119 | |
| Domain | Znf_B-box | 7.55e-04 | 81 | 165 | 5 | IPR000315 | |
| Domain | FA58C | 8.01e-04 | 21 | 165 | 3 | SM00231 | |
| Domain | FA58C_3 | 8.01e-04 | 21 | 165 | 3 | PS50022 | |
| Domain | FA58C_1 | 8.01e-04 | 21 | 165 | 3 | PS01285 | |
| Domain | FA58C_2 | 8.01e-04 | 21 | 165 | 3 | PS01286 | |
| Domain | Spectrin | 1.05e-03 | 23 | 165 | 3 | PF00435 | |
| Domain | EF-hand_dom_typ1 | 1.14e-03 | 6 | 165 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.14e-03 | 6 | 165 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.14e-03 | 6 | 165 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.14e-03 | 6 | 165 | 2 | PF09069 | |
| Domain | F5_F8_type_C | 1.20e-03 | 24 | 165 | 3 | PF00754 | |
| Domain | FA58C | 1.20e-03 | 24 | 165 | 3 | IPR000421 | |
| Domain | SCAN | 1.51e-03 | 56 | 165 | 4 | SM00431 | |
| Domain | TIMP-like_OB-fold | 1.52e-03 | 26 | 165 | 3 | IPR008993 | |
| Domain | DM_2 | 1.58e-03 | 7 | 165 | 2 | PS50809 | |
| Domain | DM | 1.58e-03 | 7 | 165 | 2 | SM00301 | |
| Domain | - | 1.58e-03 | 7 | 165 | 2 | 4.10.1040.10 | |
| Domain | TB | 1.58e-03 | 7 | 165 | 2 | PF00683 | |
| Domain | DM_DNA-bd | 1.58e-03 | 7 | 165 | 2 | IPR001275 | |
| Domain | DM | 1.58e-03 | 7 | 165 | 2 | PF00751 | |
| Domain | DM_1 | 1.58e-03 | 7 | 165 | 2 | PS40000 | |
| Domain | C1_1 | 1.61e-03 | 57 | 165 | 4 | PF00130 | |
| Domain | SCAN_BOX | 1.72e-03 | 58 | 165 | 4 | PS50804 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 4.18e-13 | 39 | 114 | 10 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 4.18e-13 | 39 | 114 | 10 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 NOTCH3 | 6.17e-12 | 68 | 114 | 11 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD4 THSD7A CFP ST3GAL4 ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 1.17e-09 | 109 | 114 | 11 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD4 THSD7A CFP ST3GAL4 ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 1.42e-09 | 111 | 114 | 11 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 AGRN NOTCH3 | 1.70e-09 | 143 | 114 | 12 | M27275 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 AGRN NOTCH3 | 8.29e-07 | 250 | 114 | 12 | M27554 |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 2.18e-04 | 37 | 114 | 4 | M554 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY | 2.18e-04 | 15 | 114 | 3 | M47816 | |
| Pubmed | THSD4 THSD7A CFP ADAMTS8 ADAMTS5 SSPOP ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS15 | 3.54e-12 | 75 | 169 | 10 | 20637190 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | RAF1 PRKD2 FBXL13 TRIM41 MAST2 CXXC1 FBXO24 NR1I2 FBXO9 EGFR TRIM32 IRAK3 PRKN PRKD1 | 4.61e-09 | 372 | 169 | 14 | 22939624 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 PRKD2 FRAS1 RHBDF2 TRIO LAT2 TMEM8B MTMR8 ZNF236 MAST2 GBA2 RADIL SYNE3 MEGF6 ADAMTS7 ZNF408 MARK4 PKD1 NLRC5 SNX11 LTBP4 AGRN ZNF687 | 4.81e-09 | 1105 | 169 | 23 | 35748872 |
| Pubmed | 3.73e-08 | 20 | 169 | 5 | 19922873 | ||
| Pubmed | ZNF438 SP3 SALL3 ZNF274 ZNF689 ZBTB8B ZNF202 LMO4 PAF1 ZNF236 RFX5 CXXC1 ZBTB44 ARFGAP2 BAZ1A ZNF451 ZNF687 ZNF646 | 9.42e-08 | 808 | 169 | 18 | 20412781 | |
| Pubmed | Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. | 1.13e-07 | 3 | 169 | 3 | 26253275 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 27662904 | ||
| Pubmed | Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart. | 1.13e-07 | 3 | 169 | 3 | 38419169 | |
| Pubmed | Expression of the protein kinase D (PKD) family during mouse embryogenesis. | 1.13e-07 | 3 | 169 | 3 | 16377259 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 32747433 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 26426580 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.58e-07 | 12 | 169 | 4 | 25770910 | |
| Pubmed | Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. | 4.49e-07 | 4 | 169 | 3 | 14743217 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 24220035 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 6.62e-07 | 101 | 169 | 7 | 20551380 | |
| Pubmed | 7.15e-07 | 64 | 169 | 6 | 22261194 | ||
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 15623513 | ||
| Pubmed | Protein kinase D regulates RhoA activity via rhotekin phosphorylation. | 1.12e-06 | 5 | 169 | 3 | 22228765 | |
| Pubmed | 1.22e-06 | 17 | 169 | 4 | 22183742 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF133 RHBDF2 TRIO TMEM8B ZNF875 FAM53A PHF6 ZNF236 SSPOP HPS3 ABCG1 UBE2J2 MEGF6 EGFR NLRC5 PRKN PRKD1 RIMS1 TAFA5 CSMD1 NBR1 NOTCH3 | 3.58e-06 | 1489 | 169 | 22 | 28611215 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.82e-06 | 248 | 169 | 9 | 24006456 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 15599946 | ||
| Pubmed | LAT2 TMEM8B SSPOP CXXC1 FBLN1 RADIL MEGF6 TRIM32 SLIT1 DMRTB1 LTBP4 AGRN NBR1 | 9.58e-06 | 608 | 169 | 13 | 16713569 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP3 TCF15 ZNF274 ZNF202 ZKSCAN2 ZNF236 RFX5 NR1I2 SALL2 KLF1 MZF1 ZNF451 SP6 DMRTB1 DMRTA2 NR5A1 | 1.01e-05 | 908 | 169 | 16 | 19274049 |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 11167130 | ||
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 1.81e-05 | 11 | 169 | 3 | 29337306 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 30841931 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29069742 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18753385 | ||
| Pubmed | RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction. | 2.35e-05 | 2 | 169 | 2 | 25240052 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10523301 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29273751 | ||
| Pubmed | Functional redundancy of protein kinase D1 and protein kinase D2 in neuronal polarity. | 2.35e-05 | 2 | 169 | 2 | 25639845 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18488137 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26807827 | ||
| Pubmed | PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. | 2.35e-05 | 2 | 169 | 2 | 15192707 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22217708 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29137610 | ||
| Pubmed | B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation. | 2.35e-05 | 2 | 169 | 2 | 33093643 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 25807436 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 34404439 | ||
| Pubmed | Analysis of RIM Expression and Function at Mouse Photoreceptor Ribbon Synapses. | 2.35e-05 | 2 | 169 | 2 | 28701482 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24336522 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 37044359 | ||
| Pubmed | RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes. | 2.35e-05 | 2 | 169 | 2 | 29606581 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22435662 | ||
| Pubmed | ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. | 2.35e-05 | 2 | 169 | 2 | 16152618 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26400943 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22936342 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28252045 | ||
| Pubmed | Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration. | 2.35e-05 | 2 | 169 | 2 | 24840177 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 31150793 | ||
| Pubmed | A presynaptic phosphosignaling hub for lasting homeostatic plasticity. | 2.35e-05 | 2 | 169 | 2 | 35443170 | |
| Pubmed | HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors. | 2.35e-05 | 2 | 169 | 2 | 23045285 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28933590 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23154421 | ||
| Pubmed | Requirement of protein kinase D1 for pathological cardiac remodeling. | 2.35e-05 | 2 | 169 | 2 | 18287012 | |
| Pubmed | The role of PKD in cell polarity, biosynthetic pathways, and organelle/F-actin distribution. | 2.35e-05 | 2 | 169 | 2 | 24492625 | |
| Pubmed | Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. | 2.35e-05 | 2 | 169 | 2 | 20819079 | |
| Pubmed | Histone deacetylase SIRT6 inhibits glioma cell growth through down-regulating NOTCH3 expression. | 2.35e-05 | 2 | 169 | 2 | 29659670 | |
| Pubmed | Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. | 2.35e-05 | 2 | 169 | 2 | 20568084 | |
| Pubmed | Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes. | 2.35e-05 | 2 | 169 | 2 | 25802335 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 14507652 | ||
| Pubmed | Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma. | 2.35e-05 | 2 | 169 | 2 | 30843621 | |
| Pubmed | RIM genes differentially contribute to organizing presynaptic release sites. | 2.35e-05 | 2 | 169 | 2 | 22753485 | |
| Pubmed | Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. | 2.35e-05 | 2 | 169 | 2 | 21296869 | |
| Pubmed | Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. | 2.35e-05 | 2 | 169 | 2 | 18234969 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23393329 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17712488 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28084409 | ||
| Pubmed | The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus. | 2.35e-05 | 2 | 169 | 2 | 22956829 | |
| Pubmed | 2.50e-05 | 35 | 169 | 4 | 33864728 | ||
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 3.49e-05 | 38 | 169 | 4 | 18267097 | |
| Pubmed | 3.61e-05 | 329 | 169 | 9 | 17474147 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 27636103 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 31104010 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 20610895 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 24143218 | ||
| Pubmed | SIRT6 regulated nucleosomal occupancy affects Hexokinase 2 expression. | 7.02e-05 | 3 | 169 | 2 | 28478957 | |
| Pubmed | RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone. | 7.02e-05 | 3 | 169 | 2 | 21262468 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 26045048 | ||
| Pubmed | Methylation of the genes ROD1, NLRC5, and HKR1 is associated with aging in Hainan centenarians. | 7.02e-05 | 3 | 169 | 2 | 29394898 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 20621130 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 21488147 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 11279031 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 26034270 | ||
| Pubmed | AMACO is a component of the basement membrane-associated Fraser complex. | 7.02e-05 | 3 | 169 | 2 | 24232570 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 28377503 | ||
| Pubmed | RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. | 7.02e-05 | 3 | 169 | 2 | 21241895 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 33741329 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 24052258 | ||
| Pubmed | Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. | 7.02e-05 | 3 | 169 | 2 | 19881544 | |
| Pubmed | Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells. | 7.02e-05 | 3 | 169 | 2 | 23359207 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 25343783 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 21423210 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 25510509 | ||
| Pubmed | NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. | 7.02e-05 | 3 | 169 | 2 | 25811463 | |
| Pubmed | Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells. | 7.02e-05 | 3 | 169 | 2 | 18195733 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 31486769 | ||
| Pubmed | ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation. | 7.02e-05 | 3 | 169 | 2 | 34324862 | |
| Interaction | ZNF707 interactions | 1.28e-08 | 79 | 160 | 9 | int:ZNF707 | |
| Interaction | ZNF408 interactions | FRAS1 TRIM41 ZBTB8B VWCE LRP1B CXXC1 ZNF408 LTBP2 LTBP4 NOTCH3 ZNF687 | 2.27e-08 | 145 | 160 | 11 | int:ZNF408 |
| Interaction | NOTCH2 interactions | RHBDF2 ZNF689 ZKSCAN2 ZNF707 ZBTB44 FBLN1 SYNE3 EGFR ADAMTS9 ZNF408 ADAMTS17 ADAMTS15 LTBP4 NOTCH3 ZNF687 ZNF646 | 2.75e-07 | 423 | 160 | 16 | int:NOTCH2 |
| Interaction | ZNF764 interactions | 7.61e-07 | 93 | 160 | 8 | int:ZNF764 | |
| Interaction | LTBP4 interactions | 1.02e-06 | 67 | 160 | 7 | int:LTBP4 | |
| Interaction | ZNF574 interactions | RAF1 DHX36 ZNF689 TRIM41 YTHDC2 ZNF467 LRP1B EGFR PRKN LTBP2 LTBP4 | 4.50e-06 | 246 | 160 | 11 | int:ZNF574 |
| Interaction | LTBP2 interactions | 5.12e-06 | 85 | 160 | 7 | int:LTBP2 | |
| Interaction | ZFP41 interactions | 5.92e-06 | 57 | 160 | 6 | int:ZFP41 | |
| Interaction | NUFIP2 interactions | THSD4 RAF1 TRIM42 KPRP SIRT6 VWCE FBLN1 MEGF6 PRKN LTBP2 LTBP4 AGRN NBR1 NOTCH3 | 6.30e-06 | 417 | 160 | 14 | int:NUFIP2 |
| Interaction | ZNF74 interactions | 6.84e-06 | 34 | 160 | 5 | int:ZNF74 | |
| Interaction | IGFL3 interactions | 2.92e-05 | 75 | 160 | 6 | int:IGFL3 | |
| Interaction | PRKD3 interactions | 3.12e-05 | 46 | 160 | 5 | int:PRKD3 | |
| Interaction | NTN5 interactions | 3.59e-05 | 24 | 160 | 4 | int:NTN5 | |
| Interaction | RBAK interactions | 4.53e-05 | 81 | 160 | 6 | int:RBAK | |
| Interaction | ZNF669 interactions | 5.70e-05 | 52 | 160 | 5 | int:ZNF669 | |
| Interaction | CFC1 interactions | 6.67e-05 | 126 | 160 | 7 | int:CFC1 | |
| Interaction | HAS1 interactions | 7.73e-05 | 11 | 160 | 3 | int:HAS1 | |
| Cytoband | 3q24 | 2.08e-04 | 31 | 170 | 3 | 3q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q24 | 7.18e-04 | 47 | 170 | 3 | chr3q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 7.58e-04 | 191 | 170 | 5 | chr11q24 | |
| Cytoband | 17q21.32 | 8.11e-04 | 49 | 170 | 3 | 17q21.32 | |
| Cytoband | 5q31 | 9.11e-04 | 115 | 170 | 4 | 5q31 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.21e-09 | 19 | 123 | 6 | 50 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF438 ZNF133 SP3 SALL3 ZNF274 ZNF875 ZNF689 ZBTB8B ZNF202 ZKSCAN2 ZNF236 ZNF467 ZNF707 ZBTB44 ZNF17 SALL2 KLF1 MZF1 ZNF451 ZNF408 SP6 ZNF646 | 2.85e-09 | 718 | 123 | 22 | 28 |
| GeneFamily | Ring finger proteins | RNF168 TRIM42 TRIM58 TRIM41 RNF222 RFFL TRIM39 RNF217 TRIM32 RLIM PDZRN3 | 2.82e-06 | 275 | 123 | 11 | 58 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.33e-04 | 18 | 123 | 3 | 91 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 2.73e-04 | 4 | 123 | 2 | 628 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 2.73e-04 | 4 | 123 | 2 | 833 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.77e-04 | 95 | 123 | 5 | 59 | |
| GeneFamily | Clustered protocadherins | 9.46e-04 | 64 | 123 | 4 | 20 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.60e-03 | 9 | 123 | 2 | 755 | |
| GeneFamily | PDZ domain containing | 3.84e-03 | 152 | 123 | 5 | 1220 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 6.54e-03 | 18 | 123 | 2 | 361 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THSD4 FRAS1 VWCE SSPOP FBLN1 LGI2 SLIT1 LTBP2 VWA2 LTBP4 AGRN | 4.33e-08 | 191 | 167 | 11 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THSD4 FRAS1 VWCE SSPOP FBLN1 LGI2 SLIT1 LTBP2 VWA2 LTBP4 AGRN | 5.64e-08 | 196 | 167 | 11 | M3008 |
| Coexpression | NABA_MATRISOME | THSD4 HGF FRAS1 ADAMTS8 ADAMTS5 ADAM32 VWCE SSPOP FBLN1 MEGF6 LGI2 ADAMTS7 ADAMTS9 FRZB WFIKKN2 SLIT1 ADAMTS17 ADAMTS15 FGF11 LTBP2 VWA2 LTBP4 AGRN | 1.20e-07 | 1008 | 167 | 23 | MM17056 |
| Coexpression | NABA_MATRISOME | THSD4 HGF FRAS1 ADAMTS8 ADAMTS5 ADAM32 VWCE SSPOP FBLN1 MEGF6 LGI2 ADAMTS7 ADAMTS9 FRZB WFIKKN2 SLIT1 ADAMTS17 ADAMTS15 FGF11 LTBP2 VWA2 LTBP4 AGRN | 1.65e-07 | 1026 | 167 | 23 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 FRAS1 VWCE SSPOP FBLN1 LGI2 SLIT1 LTBP2 VWA2 LTBP4 AGRN | 1.38e-06 | 270 | 167 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 FRAS1 VWCE SSPOP FBLN1 LGI2 SLIT1 LTBP2 VWA2 LTBP4 AGRN | 1.65e-06 | 275 | 167 | 11 | M5884 |
| Coexpression | DESCARTES_MAIN_FETAL_STELLATE_CELLS | 5.16e-05 | 63 | 167 | 5 | M40119 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | THSD4 FXYD6 ADAMTS5 CPED1 SSC5D FBLN1 LTBP2 RIMS1 LTBP4 PDZRN3 | 1.79e-09 | 179 | 169 | 10 | 02c90d8306016365ed811f0c63cfb3ac7b85464c |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | THSD4 FXYD6 ADAMTS5 CPED1 SSC5D FBLN1 MEGF6 LTBP2 RIMS1 PDZRN3 | 2.21e-09 | 183 | 169 | 10 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-08 | 183 | 169 | 9 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.92e-08 | 185 | 169 | 9 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FXYD6 ASPHD2 ADAMTS8 SSC5D FBLN1 ADAMTS17 NR5A1 CSMD1 PDZRN3 | 4.93e-08 | 190 | 169 | 9 | c7bd087f36321cec61b98657433b4d19d135791f |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FXYD6 ASPHD2 ADAMTS8 SSC5D FBLN1 ADAMTS17 NR5A1 CSMD1 PDZRN3 | 4.93e-08 | 190 | 169 | 9 | 834218fcc59df5e7e52de154272f3d55d81d0dac |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-08 | 191 | 169 | 9 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CALHM5 FXYD6 ASPHD2 ADAMTS8 SSC5D FBLN1 ADAMTS17 CSMD1 PDZRN3 | 6.16e-08 | 195 | 169 | 9 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CALHM5 FXYD6 ASPHD2 ADAMTS8 SSC5D FBLN1 ADAMTS17 CSMD1 PDZRN3 | 6.16e-08 | 195 | 169 | 9 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.33e-08 | 199 | 169 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 7.65e-08 | 200 | 169 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.82e-07 | 176 | 169 | 8 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.82e-07 | 176 | 169 | 8 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.13e-07 | 183 | 169 | 8 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.57e-07 | 185 | 169 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.57e-07 | 185 | 169 | 8 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.04e-07 | 187 | 169 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.29e-07 | 188 | 169 | 8 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-07 | 189 | 169 | 8 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.55e-07 | 189 | 169 | 8 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-07 | 191 | 169 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-07 | 191 | 169 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.67e-07 | 193 | 169 | 8 | 2b80991e7ba7640f7ab2139d30e4c54d8e533862 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.67e-07 | 193 | 169 | 8 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-07 | 193 | 169 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.67e-07 | 193 | 169 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.67e-07 | 193 | 169 | 8 | 90cfc34c2d0d7c70f071703d35db1d6037961481 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-07 | 194 | 169 | 8 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-07 | 194 | 169 | 8 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 8.62e-07 | 196 | 169 | 8 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 9.30e-07 | 198 | 169 | 8 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 9.30e-07 | 198 | 169 | 8 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 9.30e-07 | 198 | 169 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.66e-07 | 199 | 169 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.66e-07 | 199 | 169 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 9.66e-07 | 199 | 169 | 8 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.00e-06 | 200 | 169 | 8 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.00e-06 | 200 | 169 | 8 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.00e-06 | 200 | 169 | 8 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.00e-06 | 200 | 169 | 8 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.00e-06 | 200 | 169 | 8 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.00e-06 | 200 | 169 | 8 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 1.00e-06 | 200 | 169 | 8 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.00e-06 | 200 | 169 | 8 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.00e-06 | 200 | 169 | 8 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.00e-06 | 200 | 169 | 8 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.00e-06 | 200 | 169 | 8 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.68e-06 | 160 | 169 | 7 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-06 | 171 | 169 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 172 | 169 | 7 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 172 | 169 | 7 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-06 | 175 | 169 | 7 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.84e-06 | 175 | 169 | 7 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-06 | 175 | 169 | 7 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 169 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-06 | 176 | 169 | 7 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 169 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-06 | 176 | 169 | 7 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.22e-06 | 177 | 169 | 7 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-06 | 177 | 169 | 7 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-06 | 177 | 169 | 7 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.42e-06 | 178 | 169 | 7 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.42e-06 | 178 | 169 | 7 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.42e-06 | 178 | 169 | 7 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 180 | 169 | 7 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 180 | 169 | 7 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-06 | 181 | 169 | 7 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-06 | 181 | 169 | 7 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-06 | 181 | 169 | 7 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.04e-06 | 181 | 169 | 7 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.50e-06 | 183 | 169 | 7 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-06 | 186 | 169 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.48e-06 | 187 | 169 | 7 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.48e-06 | 187 | 169 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-06 | 188 | 169 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-06 | 188 | 169 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-06 | 188 | 169 | 7 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-06 | 188 | 169 | 7 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 8.02e-06 | 189 | 169 | 7 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.02e-06 | 189 | 169 | 7 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.02e-06 | 189 | 169 | 7 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-06 | 189 | 169 | 7 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 189 | 169 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.30e-06 | 190 | 169 | 7 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 190 | 169 | 7 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.30e-06 | 190 | 169 | 7 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-06 | 190 | 169 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-06 | 191 | 169 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| Drug | chloroethylclonidine | 1.19e-06 | 47 | 167 | 6 | CID000104973 | |
| Drug | 3,4,5-trimethoxybenzoic acid | 1.19e-06 | 47 | 167 | 6 | CID000008357 | |
| Drug | naphthalenesulfonamide | 4.02e-06 | 33 | 167 | 5 | CID000163571 | |
| Drug | HOE 694 | 7.21e-06 | 37 | 167 | 5 | CID000123840 | |
| Drug | Fim 1 | 7.21e-06 | 37 | 167 | 5 | CID000132906 | |
| Drug | TAPP-Br | 9.93e-06 | 19 | 167 | 4 | CID000160326 | |
| Drug | PEP005 | 1.37e-05 | 42 | 167 | 5 | CID006918670 | |
| Drug | methoxamine | 1.37e-05 | 71 | 167 | 6 | CID000006081 | |
| Drug | SC-9 | 1.54e-05 | 43 | 167 | 5 | CID000124172 | |
| Drug | agelasine B | 2.15e-05 | 46 | 167 | 5 | CID006439899 | |
| Drug | DB04780 | 3.79e-05 | 170 | 167 | 8 | CID005459389 | |
| Drug | N-desmethyl-tamoxifen-hydrochloride | 3.93e-05 | 52 | 167 | 5 | CID000035887 | |
| Drug | pseudohypericin | 4.30e-05 | 27 | 167 | 4 | CID005281751 | |
| Drug | enzastaurin | 4.32e-05 | 53 | 167 | 5 | CID000176166 | |
| Drug | SC-10 | 4.98e-05 | 28 | 167 | 4 | CID000005175 | |
| Drug | AG213 | 5.00e-05 | 89 | 167 | 6 | CID005328803 | |
| Drug | 5-CT | 5.17e-05 | 55 | 167 | 5 | CID000001809 | |
| Drug | Erlotinib | 5.35e-05 | 2 | 167 | 2 | DB00530 | |
| Drug | BFE-55 | 5.35e-05 | 2 | 167 | 2 | CID003082184 | |
| Drug | A0666_sigma | 5.64e-05 | 56 | 167 | 5 | CID000005680 | |
| Disease | cortical surface area measurement | ZNF438 THSD4 USP34 PRKD2 HGF FBXL13 TMEM8B MAST2 CPED1 MEGF6 EGFR ADAMTS7 ADAMTS9 FRZB PKD1 DMRTA2 PRKD1 MED23 PDZRN3 ERCC6L2-AS1 | 3.27e-05 | 1345 | 157 | 20 | EFO_0010736 |
| Disease | candidiasis (implicated_via_orthology) | 8.87e-05 | 44 | 157 | 4 | DOID:1508 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 1.68e-04 | 4 | 157 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.68e-04 | 4 | 157 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | arginine measurement | 2.42e-04 | 23 | 157 | 3 | EFO_0020990 | |
| Disease | scoliosis (implicated_via_orthology) | 2.78e-04 | 5 | 157 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | pallidum volume change measurement, age at assessment | 3.12e-04 | 25 | 157 | 3 | EFO_0008007, EFO_0021494 | |
| Disease | Glioblastoma Multiforme | 3.26e-04 | 111 | 157 | 5 | C1621958 | |
| Disease | artificially sweetened beverage consumption measurement | 4.16e-04 | 6 | 157 | 2 | EFO_0010096 | |
| Disease | pulse pressure measurement | ZNF438 THSD4 USP34 ST3GAL4 ADAMTS8 MAST2 SSPOP PRKD3 ADRA1B SLIT1 PKD1 ADAMTS15 DMRTA2 SLC25A47 LTBP2 NEURL1B SNX11 NOTCH3 | 4.57e-04 | 1392 | 157 | 18 | EFO_0005763 |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 7.71e-04 | 8 | 157 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 7.71e-04 | 8 | 157 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Glioblastoma | 8.50e-04 | 79 | 157 | 4 | C0017636 | |
| Disease | cortical thickness | ZNF438 THSD4 FBXL13 ADAMTS8 MAST2 CPED1 ABCG1 VPS13D EGFR ADAMTS7 ADAMTS9 BAZ1A PKD1 KLHL18 ERCC6L2-AS1 | 9.17e-04 | 1113 | 157 | 15 | EFO_0004840 |
| Disease | sleep latency | 1.01e-03 | 37 | 157 | 3 | EFO_0005280 | |
| Disease | Giant Cell Glioblastoma | 1.07e-03 | 84 | 157 | 4 | C0334588 | |
| Disease | interleukin 2 measurement | 1.36e-03 | 41 | 157 | 3 | EFO_0008331 | |
| Disease | triacylglycerol 44:1 measurement | 1.79e-03 | 12 | 157 | 2 | EFO_0010399 | |
| Disease | serum IgG glycosylation measurement | 2.02e-03 | 523 | 157 | 9 | EFO_0005193 | |
| Disease | gastroesophageal reflux disease | 2.11e-03 | 101 | 157 | 4 | EFO_0003948 | |
| Disease | Neoplasm of lung | 2.45e-03 | 14 | 157 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 2.45e-03 | 14 | 157 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 2.45e-03 | 14 | 157 | 2 | 211980 | |
| Disease | neuritic plaque measurement | 2.74e-03 | 349 | 157 | 7 | EFO_0006798 | |
| Disease | lower face morphology measurement | 2.78e-03 | 109 | 157 | 4 | EFO_0010948 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.80e-03 | 447 | 157 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | monoclonal gammopathy | 2.85e-03 | 53 | 157 | 3 | EFO_0000203 | |
| Disease | response to cisplatin, platinum measurement | 2.85e-03 | 53 | 157 | 3 | EFO_0010154, GO_0072718 | |
| Disease | Liver Cirrhosis, Experimental | HGF FXYD6 NPDC1 CFP DIPK2A ABCG1 ADRA1B FBXO9 NLRC5 PLSCR2 PDZRN3 | 2.97e-03 | 774 | 157 | 11 | C0023893 |
| Disease | Barrett Epithelium | 3.21e-03 | 16 | 157 | 2 | C1258085 | |
| Disease | Schizoaffective disorder-bipolar type | 3.21e-03 | 16 | 157 | 2 | EFO_0009965 | |
| Disease | Barrett Esophagus | 3.21e-03 | 16 | 157 | 2 | C0004763 | |
| Disease | gout, hyperuricemia | 3.21e-03 | 16 | 157 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | von Willebrand factor measurement | 3.33e-03 | 56 | 157 | 3 | EFO_0004629 | |
| Disease | erythritol measurement | 3.63e-03 | 17 | 157 | 2 | EFO_0021171 | |
| Disease | urate measurement, spine bone mineral density | 3.68e-03 | 58 | 157 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | gout | 4.06e-03 | 196 | 157 | 5 | EFO_0004274 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.54e-03 | 125 | 157 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.54e-03 | 125 | 157 | 4 | C1879321 | |
| Disease | carcinoma (implicated_via_orthology) | 4.86e-03 | 64 | 157 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | lymphocyte count | SH3TC2 FRAS1 PCDHGC4 TRIM58 ZNF689 NPDC1 ST3GAL4 EGFR MARK4 IL21 SP6 NLRC5 PRKN LTBP2 NEURL1B VWA2 | 5.10e-03 | 1464 | 157 | 16 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTRRCQCRLGPRKVA | 216 | P0DSO1 | |
| KPNVCSRLSRRALGC | 6 | Q5H9S7 | |
| CEQRLALRCGTARRP | 676 | Q9BZ76 | |
| CKSPFILVGSSRRVC | 3181 | Q96PZ7 | |
| LCRKEGLCQIVRRFP | 191 | A4D0V7 | |
| NGLPRDLRCFRKVSC | 146 | P45844 | |
| RLYSNSVCVRGKCVR | 691 | Q9UNA0 | |
| GVSPRDRCKLFCRAR | 616 | Q9UP79 | |
| FCRKRRTGCSGPFQA | 46 | Q8N2C3 | |
| FNAVCLSRRGRPRCS | 401 | O00468 | |
| KRAFVRILGCQCRGR | 356 | P35368 | |
| NLICGRLVCTYPTRK | 546 | Q8TC27 | |
| RLRAVPTNKACFDCG | 16 | Q8N6H7 | |
| ILSRRCKCSFNQKPR | 56 | Q9H0Q3 | |
| RTPKCARCRNHGVVS | 66 | Q96SC8 | |
| CCTRGLIRPVSASFL | 16 | P05496 | |
| SKSCGRGFQRRSLKC | 906 | Q8TE58 | |
| SRTCGTGARFRQRKC | 556 | Q8TE56 | |
| RKRFRLCNLQACPAG | 581 | Q9UKP4 | |
| FCPECRPKQRSRRLS | 1191 | Q9NRL2 | |
| LKVRGLQPECCAVFR | 86 | P04049 | |
| SCPARCRGRLSAKEL | 51 | Q9UPQ7 | |
| CCRPLSTANFGKIIR | 126 | P48382 | |
| CRRSRAASVGRCSVP | 716 | Q9Y5E7 | |
| GFCTACKAPFTVIRR | 821 | Q9HCC9 | |
| RLRAVPQSCRLCGAA | 371 | Q96JH8 | |
| GSLLSSCCPRRAKRR | 526 | Q9NSA2 | |
| KRCAFKIPNNCSGVR | 186 | Q15139 | |
| CLPLRCGKGQSRARR | 256 | Q86XX4 | |
| VKFLCPSTRPHRCRN | 3711 | Q9NZR2 | |
| IKTSVFCRCKPGFQR | 3821 | Q9NZR2 | |
| LGCPLTLRCKNFRVA | 66 | Q96EF0 | |
| KCFTCSTCRNRLVPG | 111 | P61968 | |
| VLRGCLHRRKAPSCT | 496 | A6NDA9 | |
| CSLKPRQGCFHYSRR | 51 | Q99665 | |
| FCIRNCCGRSRPFTL | 136 | Q9NRY7 | |
| CCGRSRPFTLRITDN | 141 | Q9NRY7 | |
| SRLLSRKRAVPCGAC | 86 | P47881 | |
| RKRAVPCGACLTQLF | 91 | P47881 | |
| TRRCCSFIAQVLPSR | 236 | P31512 | |
| TFRPTARINSICGRC | 211 | Q9ULK4 | |
| LVSCCRRKPFALVCG | 276 | Q6IPT4 | |
| SVVAGTARFSCRCPR | 96 | Q9UM47 | |
| AFSIPNNCSGARKRR | 181 | Q9BZL6 | |
| CAFKIPNNCSGVRKR | 196 | O94806 | |
| ANRCTRNKGLPFTCK | 71 | P14210 | |
| PRNFSAKLFCLAGRC | 411 | Q9Y616 | |
| PAPSRCCRRRSSVAF | 86 | O15297 | |
| TRTRRRACNHPAPKC | 156 | P27918 | |
| RCPFRKGACEITRKT | 76 | O75469 | |
| FPAGTCACLTRSRRR | 726 | Q9Y5F7 | |
| CRRSRAASVGRCSVP | 716 | Q9UN67 | |
| FCRPHNICTFVPRRK | 181 | P24158 | |
| NICTFVPRRKAGICF | 186 | P24158 | |
| LGFRQRCIPRSLCLS | 1101 | Q86WI3 | |
| CPALCLQADRGRRVF | 226 | Q8TB68 | |
| RTKFCARCGGRVSLR | 136 | Q86UR5 | |
| AQRRVCPRGTKSLCQ | 26 | Q92914 | |
| ACPGSLDCALKRRAR | 41 | Q9NQX5 | |
| GIRPFRCSACGKAFT | 146 | O00110 | |
| FCARCGGRVSLRSNK | 146 | Q9UQ26 | |
| FRCRPKLQCKSGFIQ | 286 | P23142 | |
| LCRRSRAAPVGRCSV | 711 | Q9Y5E2 | |
| RSGVVCRVKYCNSLP | 26 | Q8N7H5 | |
| TGPRESDCLVCRKFR | 241 | P00533 | |
| KCPRTYRLLGSLRTC | 246 | Q6ICH7 | |
| KSCDGGTQRRRAICV | 1011 | Q9P2N4 | |
| TGDFCRLPKRQCNRH | 576 | Q9P0U4 | |
| RKHTGQRPFRCQLCP | 331 | Q13351 | |
| FRTRPRCCTSIAGLI | 276 | O94889 | |
| AVCVSSKLRPRGQCR | 391 | Q9HCG7 | |
| VRTPKCSRCRNHGFL | 6 | Q96MA1 | |
| RPCRAARGSLQKTSA | 66 | Q9UK97 | |
| ARCTLCRTFPITGLR | 226 | A2CJ06 | |
| LFTGCCVNPRKIFPR | 76 | Q8N5C1 | |
| CVNPRKIFPRGHSCR | 81 | Q8N5C1 | |
| RRPGCSLLEKQRIAC | 131 | A0A1W2PPK0 | |
| RGKGSACRIVCTQPR | 251 | Q9H2U1 | |
| LDQSICKRATGRPRC | 121 | Q8NDZ4 | |
| CKRATGRPRCDLLQA | 126 | Q8NDZ4 | |
| CSKGLQRKGPCERRR | 21 | Q5XKL5 | |
| RGRCVRLAKRCSPSS | 51 | Q8WZB0 | |
| NAGRRQKHRLTCPSC | 111 | Q9HBE4 | |
| AATARLFRPLAKRCC | 76 | P27544 | |
| CLLRPKTFRSVSHCR | 231 | Q8NEE6 | |
| PAACRCSGLARRVLT | 11 | Q92839 | |
| CSRPQLCVCRSGFRG | 201 | Q14767 | |
| RRRVKRSCPSCGSEL | 11 | O75426 | |
| RSLGARCRNSIASCP | 36 | Q96L34 | |
| LPRRGSFCRTSNRKS | 161 | Q6P0Q8 | |
| CPGQTSRRSRCIRAF | 56 | Q8N2S1 | |
| CIRAFCRVRSCQPKK | 66 | Q8N2S1 | |
| RRPISSCSQRRGPKC | 311 | Q5T749 | |
| SCSQRRGPKCRIEIS | 316 | Q5T749 | |
| SGSCPRCERLQARRE | 926 | Q92622 | |
| CKVCGRAFSTRGNLR | 661 | Q9Y467 | |
| RPFKCNICGNRFSTK | 446 | Q9BXA9 | |
| KERPFVCALCRRGCS | 1001 | Q9BXA9 | |
| TSQRIACPRPYCKRI | 136 | Q86T03 | |
| LARCPHCRKVSSIGR | 191 | Q86T03 | |
| SICRQCPIKGFRYRS | 611 | Q13474 | |
| CEQRLALRCGTARRP | 676 | Q96NU0 | |
| PRSRFTRIQRATCCV | 3271 | P98161 | |
| TITRHRCQCRPGFQL | 221 | O75095 | |
| AASLCVRCSRPGAKR | 21 | Q9GZY6 | |
| RTCARCQESLGRLSP | 61 | Q96C24 | |
| TRCRALPALATCSRQ | 6 | Q7L3T8 | |
| ARCACRKGQIAGTTR | 66 | Q7Z5A7 | |
| DQPKSCCFLPRSGRR | 176 | Q9Y5W9 | |
| QRKRCPFCRFQKCLT | 61 | Q13285 | |
| INGVRCPFCSKITRI | 56 | Q13049 | |
| RSCGRRLPRQFCRSC | 101 | Q13049 | |
| CPVCRKTSRYRSLRP | 66 | Q9HCM9 | |
| APRRCFTCPQCRKSF | 176 | Q8WV44 | |
| RSSGPILCQVCRNKR | 231 | Q8IWZ5 | |
| PRKFGQGSRSCRVCS | 11 | P62273 | |
| RGIHRKARRCQTEPC | 1951 | A2VEC9 | |
| RVQPGKLRVQCSTCR | 156 | O60260 | |
| SCRPALQIKKCGRFE | 321 | Q8IYX7 | |
| CGPGRQARAITCRKQ | 861 | Q9UPZ6 | |
| CLGRNCKLPITQRLS | 246 | Q6ZMZ3 | |
| LSREFCTPRIRGNTC | 171 | Q5JRV8 | |
| LCQPRCAFSTLGRVL | 51 | Q969F9 | |
| RSAQVRRLARCPATC | 26 | Q8N0V4 | |
| QRRIVGVRYQCSLCP | 221 | Q14596 | |
| GPRLCLLCQRFRATA | 81 | Q8WZ73 | |
| SSIPKNIQSLRCRRC | 106 | Q11206 | |
| PRVLFKGLVLNCCRA | 271 | Q6Q0C1 | |
| FCVKSRSRRCVNGPL | 56 | Q8TF17 | |
| GQRRPSLAKRQVFCS | 151 | Q8TC41 | |
| RRSVPRSSGQTVCRC | 216 | Q3SY56 | |
| LRCRGNETALRFCPA | 371 | A1L4H1 | |
| CTVAKARGLRACRGE | 166 | Q8N6T7 | |
| QGCARCFATSPRLRA | 26 | Q9BYC2 | |
| RFCSIACQRPVGLVL | 516 | Q9UNK9 | |
| PRSICTFCLSNQRKG | 161 | Q12870 | |
| CFRQCVPRVSVKLGS | 66 | Q8TCV5 | |
| TAFPCQVLTQRCGRR | 146 | Q96C28 | |
| NRIGCFFLHPRCSKR | 936 | Q9Y4E5 | |
| PTRQRKCGFCKSNRD | 11 | Q8IWS0 | |
| RGASSERCKCKPIRA | 171 | Q92765 | |
| EGKRLRRVACTCPNC | 591 | Q02447 | |
| PRSARAFCCRSRALL | 181 | A6NCQ9 | |
| TCPICRRAVLASGNR | 606 | Q9NVW2 | |
| VCRCSECGKIFRNPR | 506 | Q96GC6 | |
| CPQCGRAYTLATKLR | 581 | Q9H9D4 | |
| ITPNGRFKCNTRLCL | 81 | Q8N2K1 | |
| SCGLRLKRQARACCP | 526 | A8MQ27 | |
| CPTCGVRFTRIQNLK | 401 | Q8NCP5 | |
| KLCSRQRPGCRTQAL | 516 | Q5GFL6 | |
| CTCRPGFRLRADRVS | 246 | Q96DN2 | |
| RTAVRCALCGRSFPG | 1361 | O15015 | |
| AACRPGCSQKLRVRF | 91 | O95685 | |
| RRTLFIGCQPKCVRT | 1316 | Q8WWQ8 | |
| ALRSLCGVGPRFVRC | 156 | A6NDV4 | |
| VCRRSAFPKACIAGL | 111 | A6NLC8 | |
| CVCSRRGLAPRGRSA | 81 | A0A0U1RQS6 | |
| KASLCCPFCRRRVSS | 46 | Q8IYW5 | |
| VCRECGRGFNRKSTL | 271 | P52736 | |
| FLLSQRKPGCCRSQS | 156 | P0C7T8 | |
| CRIFCTQPRRLAAIA | 241 | Q9H6S0 | |
| PDCGRCFRRSRSLAN | 236 | Q96CS4 | |
| LRECGFLRTPEQCRT | 381 | Q63HK3 | |
| FKCPHCELRFRTSGR | 1251 | Q9UL36 | |
| RLCERSFCSAPSLRR | 996 | Q8N1G0 | |
| ICRKCGRGFSRKSNL | 636 | P10072 | |
| GILRLCCEQSPAFTR | 2856 | Q70CQ2 | |
| KSCQGGFRVREVRCL | 926 | Q6ZMP0 | |
| GCCQGLRLKRRKFTF | 1496 | O75093 | |
| TGQRCRVVKRSFAFP | 261 | Q6PJF5 | |
| FVADCLCPSKRRRPQ | 201 | Q9H3N1 | |
| SCRICRKSYVRPGSL | 536 | Q7Z4V0 | |
| RPCRCNECGKSFSRR | 591 | O95125 | |
| RPFECSICGKSFRCR | 496 | P17021 | |
| PFACAQCGRRFSRKS | 486 | Q7Z7K2 | |
| ACCIPGRRELLRKFQ | 276 | Q8NG06 | |
| TVVLRCRVCGRPKAS | 2701 | O75962 | |
| RACKPRQKLVTSFCR | 446 | Q8TEU8 | |
| RTQAQRVRKPRCCTG | 4221 | Q5THJ4 | |
| VHRSNRPIICKGCRR | 391 | Q8NAP8 | |
| RPIICKGCRRTFTSH | 396 | Q8NAP8 | |
| LRCRSQPCVLSGKRS | 256 | Q6NSI3 | |
| CAECGKAFRQRPTLT | 571 | P28698 |